Inivata: Peter Collins
Inivata has appointed Peter Collins as the firm's chief business officer. Prior to Inivata, Collins most recently held senior leadership positions at Guardant Health. He has also served as chief business officer at Yourgene Health. Prior to Yourgene, Collins served as VP, head of diagnostics at GSK, as well as VP of pharma business development at Qiagen. He was also the founder and board member of Epemed.
Exact Sciences: Eli Casdin
In a filing with the US Securities and Exchange Comission, Exact Sciences said that board member Eli Casdin had submitted his resignation from the company's board of directors, effective Sept. 21. Casdin is the chief investment officer and founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry.
Euformatics: Tommi Kaasalainen
Euformatics has named Tommi Kaasalainen as CEO. He replaces Olli Pasanen, who remains chairman of the Finnish genomic informatics firm. Kaasalainen joins Euformatics after serving as CEO of Nukute, a startup maker of wireless sensors for sleep apnea diagnostics. He also was executive VP of Innokas Medical, a medical device manufacturer in Finland.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.